Brege Laura bought PCRX
June 10, 2026 · Form 4 insider transaction
Brege Laura bought 10,891 shares of Pacira BioSciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,891
Price
$0.00
Total value
N/A
InsiderBrege Laura
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after10,891
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.